GlassScriptPhysician profile
Kirk R Davis
NPI 1639152978
$10,229.51
in general payments reported to CMS, 2019-2025
18 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2020: $276 · 2021: $411 · 2022: $2,387 · 2023: $2,524 · 2024: $1,423 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,866 · Food and Beverage: $2,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,865.58 |
| Food and Beverage | $2,324.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,921.02 | 2022-2025 | Distal Extremities Implants Trauma |
| Rock Medical Orthopedics, INC. | $1,701.16 | 2021-2023 | |
| Cdc Medical LLC | $1,207.62 | 2019 | |
| Smith+Nephew, INC. | $836.41 | 2019-2025 | Evos |
| Medacta USA, INC. | $744.46 | 2021-2022 | |
| Miach Orthopaedics, INC. | $421.84 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $259.57 | 2019-2024 | Persona |
| Amgen INC. | $244.72 | 2019 | |
| Stryker Corporation | $206.98 | 2023 | Gamma, T2 Alpha, Hoffmann |
| Vericel Corporation | $180.25 | 2019-2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $118.96 | 2025 | |
| Boston Scientific Corporation | $104.11 | 2023 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $74.80 | 2022-2024 | Twistr, Rigidloop |
| Trimed, INC. | $53.88 | 2022 | |
| Heron Therapeutics, INC. | $50.64 | 2022-2023 | Zynrelef |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $49.98 | 2023-2024 | Gelsyn-3, Durolane |
| Radius Health, INC. | $32.05 | 2024-2025 | Tymlos |
| Nexus Medical Technologies LLC | $21.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.